MacroGenics to Participate in the Stifel 2025 Healthcare Conference

MacroGenics to Participate in the Stifel 2025 Healthcare Conference GlobeNewswire November 06, 2025 ROCKVILLE, MD, Nov. 06, 2025 (GLOBE NEWSWIRE) — MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, today announced that Eric Risser, President and CEO of MacroGenics, will participate in a fireside chat […]

Galecto Reports Third Quarter 2025 Operating and Financial Results

Galecto Reports Third Quarter 2025 Operating and Financial Results GlobeNewswire November 06, 2025 BOSTON, Nov. 06, 2025 (GLOBE NEWSWIRE) — Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company focused on the development of novel treatments for oncology and liver diseases, today announced its operating and financial results for the quarter ended September 30, 2025. “During

Rani Therapeutics Reports Third Quarter 2025 Financial Results; Provides Corporate Update

Rani Therapeutics Reports Third Quarter 2025 Financial Results; Provides Corporate Update GlobeNewswire November 06, 2025 – Announced up to $1.085 billion collaboration with Chugai Pharmaceutical Co. for multiple high-value therapeutics – – Completed $60.3 million oversubscribed private placement led by Samsara BioCapital with participation from RA Capital Management, Anomaly, Special Situations Funds, and Invus –

Strawberry Fields REIT Announces Q4 2025 Cash Dividend of $0.16 per Common Share

Strawberry Fields REIT Announces Q4 2025 Cash Dividend of $0.16 per Common Share GlobeNewswire November 06, 2025 SOUTH BEND, Ind., Nov. 06, 2025 (GLOBE NEWSWIRE) — Strawberry Fields REIT, Inc. (NYSE AMERICAN: STRW) (the “Company”) today announced that its Board of Directors declared a cash dividend on its common stock in the amount of $0.16

Sutro Biopharma Reports Third Quarter 2025 Financial Results and Business Highlights

Sutro Biopharma Reports Third Quarter 2025 Financial Results and Business Highlights GlobeNewswire November 06, 2025 – Company announces U.S. FDA clearance of Investigational New Drug (IND) application for STRO-004, its potential best-in-class Tissue Factor ADC; Expects to dose first patient before year-end – – Company presented new preclinical data at World ADC and SITC, highlighting

Brookfield Property Partners Declares Quarterly Dividends on Listed Preferred Units

Brookfield Property Partners Declares Quarterly Dividends on Listed Preferred Units GlobeNewswire November 06, 2025 All dollar references are in U.S. dollars, unless noted otherwise. BROOKFIELD NEWS, Nov. 06, 2025 (GLOBE NEWSWIRE) — Brookfield Property Partners (“BPY” or the “Partnership”) announced today that the Board of Directors has declared quarterly distributions on the Partnership's Class A

Host Hotels & Resorts Provides Updated Third Quarter 2025 Investor Presentation

Host Hotels & Resorts Provides Updated Third Quarter 2025 Investor Presentation GlobeNewswire November 06, 2025 BETHESDA, Md., Nov. 06, 2025 (GLOBE NEWSWIRE) — Host Hotels & Resorts, Inc. (NASDAQ: HST) (the “Company”), the nation's largest lodging real estate investment trust, today provided an updated investor presentation for third quarter 2025 results. The investor presentation can

Mercer International Inc. Reports Third Quarter 2025 Results

Mercer International Inc. Reports Third Quarter 2025 Results GlobeNewswire November 06, 2025 Selected Highlights Third quarter Operating EBITDA* of negative $28.1 million (net loss of $80.8 million), including a non-cash inventory impairment of $20.4 million, compared to positive $50.5 million (net loss of $17.6 million) in the same quarter of 2024 Combined industry wide challenges

Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08

Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08 GlobeNewswire November 06, 2025 NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) — Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued an inducement award to a new employee. Effective November 1, 2025, in connection with commencing employment as Chief

Southside Bancshares, Inc. Declares Cash Dividend

Southside Bancshares, Inc. Declares Cash Dividend GlobeNewswire November 06, 2025 TYLER, Texas, Nov. 06, 2025 (GLOBE NEWSWIRE) — The Board of Directors of Southside Bancshares, Inc., (NYSE:SBSI), parent company of Southside Bank declared a regular quarterly cash dividend of $0.36 per common share. The cash dividend of $0.36 is scheduled for payment on December 4,

Scroll to Top